Current Status of postoperative radiation for non-small-cell lung cancer

Seminars in Radiation Oncology

Volumn 20, Issue 3, 2010, Pages 192-200

  Saynak, Mert ^a,b   Higginson, Daniel S ^a   Morris, David E ^a   Marks, Lawrence B ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b TRAKYA UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; LOMUSTINE; PACLITAXEL; VINCRISTINE;

ADJUVANT CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CLINICAL TRIAL; HUMAN; LUNG NON SMALL CELL CANCER; MULTIPLE CYCLE TREATMENT; OVERALL SURVIVAL; PNEUMONIA; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; THREE DIMENSIONAL IMAGING; TREATMENT PLANNING;

CARCINOMA, NON-SMALL-CELL LUNG; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; HUMANS; LUNG NEOPLASMS; POSTOPERATIVE CARE; RADIATION PNEUMONITIS; RADIOTHERAPY, CONFORMAL; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SURVIVAL RATE; TUMOR BURDEN;

EID: 77954842219     PISSN: 10534296     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semradonc.2010.01.008     Document Type: Review

References (52)

1. Kelsey C.R., Marks L.B., Hollis D., et al. Local recurrence after surgery for early stage lung cancer: An 11-year experience with 975 patients. Cancer 2000, 115:5218-5227.
2. Saynak M, Veeramachaneni NK, Hubbs JL, et al: Local failure after Complete resection of "Early-Stage" non-small cell lung cancer: The potential role of post-operative radiation therapy. Poster presentation at the 51st Annual Meeting of the American Society for Therapeutic Radiology and Oncology (ASTRO), November 1-5, 2009, Chicago, IL.
3. Effects of postoperative mediastinal radiation on completely resected stage II and stage III epidermoid cancer of the lung. N Engl J Med 1986, 315:1377-1381. The Lung Cancer Study Group.
4. Stephens R.J., Girling D.J., Bleehen N.M., et al. The role of post-operative radiotherapy in non-small-cell lung cancer: A multicentre randomised trial in patients with pathologically staged T1-2, N1-2, M0 disease. Medical Research Council Lung Cancer Working party. Br J Cancer 1996, 74:632-639.
5. Mayer R., Smolle-Juettner F.M., Szolar D., et al. Postoperative radiotherapy in radically resected non-small cell lung cancer. Chest 1997, 112:954-959.
6. Van Houtte P., Rocmans P., Smets P., et al. Postoperative radiation therapy in lung caner: A controlled trial after resection of curative design. Int J Radiat Oncol Biol Phys 1980, 6:983-986.
7. Postoperative radiotherapy in non-small-cell lung cancer: Systematic review and meta-analysis of individual patient data from nine randomised controlled trials. Lancet 1998, 352:257-263. PORT Meta-analysis Trialists Group.
8. Wang M., Gu X.Z., Yin W.B., et al. Randomised clinical trial of postoperative irradiation after surgery for non-small cell lung carcinoma. Chin J Radiol Oncol 1994, 3:39-43.
9. Lafitte J.J., Ribet M.E., Prevost B.M., et al. Postresection irradiation for T2N0M0 non-small cell carcinoma: A prospective, randomized study. Ann Thorac Surg 1996, 62:830-834.
10. Dautzenberg B., Arriagada R., Chammard A.B., et al. A controlled study of postoperative radiotherapy for patients with completely resected nonsmall cell lung carcinoma; Groupe d: Etude et de Traitement des cancers Bronchiques. Cancer 1999, 86:265-273.
11. Debevec M., Bitenc M., Vidmar S., et al. Postoperative radiotherapy for radically resected N2 non-small-cell lung cancer (NSCLC): Randomised clinical study 1988-92. Lung Cancer 1996, 14:99-107.
12. Trodella L., Granone P., Valente S., et al. Adjuvant radiotherapy in non-small cell lung cancer with pathological stage I: Definitive results of a phase III randomized trial. Radiother Oncol 2002, 62:11-19.
13. Miles E.F., Kelsey C.R., Kirkpatrick J.P., et al. Estimating the magnitude and field-size dependence of radiotherapy-induced mortality and tumor control after postoperative radiotherapy for non-small-cell lung cancer: Calculations from clinical trials. Int J Radiat Oncol Biol Phys 2007, 68:1047-1052.
14. Lally B.E., Zelterman D., Colasanto J.M., et al. Postoperative radiotherapy for stage II or III non-small-cell lung cancer using the surveillance, epidemiology, and end results database. J Clin Oncol 2006, 24:2998-3006.
15. Matsuguma H., Nakahara R., Ishikawa Y., et al. Postoperative radiotherapy for patients with completely resected pathological stage IIIA-N2 non-small cell lung cancer: Focusing on an effect of the number of mediastinal lymph node stations involved. Interact Cardiovasc Thorac Surg 2008, 7:573-577.
16. Arriagada R., Bergman B., Dunant A., et al. Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer. N Engl J Med 2004, 350:351-360.
17. Douillard J.Y., Rosell R., De Lena M., et al. Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non-small-cell lung cancer (adjuvant Navelbine International Trialist Association [Anita]): A randomised controlled trial. Lancet Oncol 2006, 7:719-727.
18. Winton T., Livingston R., Johnson D., et al. Vinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancer. N Engl J Med 2005, 352:2589-2597.
19. Dautzenberg B., Chastang C., Arriagada R., et al. Adjuvant radiotherapy versus combined sequential chemotherapy followed by radiotherapy in the treatment of resected nonsmall cell lung carcinoma. A randomized trial of 267 patients. Cancer 1995, 76:779-786. GETCB (Groupe d'Etude et de Traitement des Cancers Bronchiques).
20. Keller S.M., Adak S., Wagner H., et al. A randomized trial of postoperative adjuvant therapy in patients with completely resected stage II or IIIA non-small-cell lung cancer. Eastern Cooperative Oncology Group. N Engl J Med 2000, 343:1217-1222.
21. Bradley J.D., Paulus R., Graham M.V., et al. Phase II trial of postoperative adjuvant paclitaxel/carboplatin and thoracic radiotherapy in resected stage II and IIIA non-small-cell lung cancer: Promising long-term results of the Radiation Therapy Oncology Group-RTOG 9705. J Clin Oncol 2005, 23:3480-3487.
22. Feigenberg S.J., Hanlon A.L., Langer C., et al. A phase II study of concurrent carboplatin and paclitaxel and thoracic radiotherapy for completely resected stage II and IIIA non-small cell lung cancer. J Thorac Oncol 2007, 2:287-292.
23. Douillard J.Y., Rosell R., De Lena M., et al. Impact of postoperative radiation therapy on survival in patients with complete resection and stage I, II, or IIIA non-small-cell lung cancer treated with adjuvant chemotherapy: The adjuvant Navelbine International Trialist Association (ANITA) Randomized Trial. Int J Radiat Oncol Biol Phys 2008, 72:695-701.
24. Perry M.C., Kohman L.J., Bonner J.A., et al. A phase III study of surgical resection and paclitaxel/carboplatin chemotherapy with or without adjuvant radiation therapy for resected stage III non-small-cell lung cancer. Cancer and Leukemia Group B. Clin Lung Cancer 2007, 8:268-272.
25. Wind J., Smit E.J., Senan S., et al. Residual disease at the bronchial stump after curative resection for lung cancer. Eur J Cardiothorac Surg 2007, 32:29-34.
26. Kaiser L.R., Fleshner P., Keller S., et al. Significance of extramucosal residual tumor at the bronchial resection margin. Ann Thorac Surg 1989, 47:265-269.
27. Law M.R., Henk J.M., Lennox S.C., et al. Value of radiotherapy for tumour on the bronchial stump after resection for bronchial carcinoma. Thorax 1982, 37:496-499.
28. Gebitekin C., Gupta N.K., Satur C.M., et al. Fate of patients with residual tumour at the bronchial resection margin. Eur J Cardio Thorac Surg 1994, 8:339-342.
29. Kelsey C.R., Clough R.W., Marks L.B. Local recurrence following initial resection of NSCLC: Salvage is possible with radiation therapy. Cancer J 2006, 12:283-288.
30. Kelsey C.R., Light K.L., Marks L.B. Patterns of failure after resection of non-small-cell lung cancer: Implications for postoperative radiation therapy volumes. Int J Radiat Oncol Biol Phys 2006, 65:1097-1105.
31. Kocak Z., Yu X., Zhou S.M., et al. The impact of pre-radiotherapy surgery on radiation-induced lung injury. Clin Oncol R Coll Radiol 2005, 17:210-216.
32. Miles E.F., Larrier N.A., Kelsey C.R., et al. Intensity-modulated radiotherapy for resected mesothelioma: The Duke Experience. Int J Radiat Oncol Biol Phys 2008, 71:1143-1150.
33. Yorke E.D., Jackson A., Rosenzweig K.E., et al. Correlation of dosimetric factors and radiation pneumonitis for non-small-cell lung cancer patients in a recently completed dose escalation study. Int J Radiat Oncol Biol Phys 2005, 63:672-682.
34. Hernando M.L., Marks L.B., Bentel G.C., et al. Radiation-induced pulmonary toxicity: A dose-volume histogram analysis in 201 patients with lung cancer. Int J Radiat Oncol Biol Phys 2001, 51:650-659.
35. Kong F.M., Hayman J.A., Griffith K.A., et al. Final toxicity results of a radiation-dose escalation study in patients with non-small-cell lung cancer (NSCLC): Predictors for radiation pneumonitis and fibrosis. Int J Radiat Oncol Biol Phys 2006, 65:1075-1086.
36. Wang S., Liao Z., Wei X., et al. Analysis of clinical and dosimetric factors associated with treatment-related pneumonitis (TRP) in patients with non-small-cell lung cancer (NSCLC) treated with concurrent chemotherapy and three-dimensional conformal radiotherapy (3D-CRT). Int J Radiat Oncol Biol Phys 2006, 66:1399-1407.
37. Seppenwoolde Y., De Jaeger K., Boersma L.J., et al. Regional differences in lung radiosensitivity after radiotherapy for non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2004, 60:748-758.
38. Hope A.J., Lindsay P.E., El Naqa I., et al. Modeling radiation pneumonitis risk with clinical, dosimetric, and spatial parameters. Int J Radiat Oncol Biol Phys 2006, 65:112-124.
39. Martel M.K., ten Haken R.K., Hazuka M.B., et al. Dose-volume histogram and 3-D treatment planning evaluation of patients with pneumonitis. Int J Radiat Oncol Biol Phys 1994, 28:575-581.
40. Oetzel D., Schraube P., Hensley F., et al. Estimation of pneumonitis risk in three-dimensional treatment planning using dose-volume histogram analysis. Int J Radiat Oncol Biol Phys 1995, 33:455-460.
41. Rancati T., Ceresoli G.L., Gagliardi G., et al. Factors predicting radiation pneumonitis in lung cancer patients: A retrospective study. Radiother Oncol 2003, 67:275-283.
42. Kim T.H., Cho K.H., Pyo H.R., et al. Dose-volumetric parameters for predicting severe radiation pneumonitis after three-dimensional conformal radiation therapy for lung cancer. Radiology 2005, 235:208-215.
43. Marks L.B., Bentzen S.M., Deasy J.O., et al. Radiation dose volume effects in the lung. Int J Radiat Oncol Biol Phys 2010, 76(suppl 3):S70-S76.
44. Feng Q.F., Wang M., Wang L.J., et al. A study of postoperative radiotherapy in patients with non-small-cell lung cancer: A randomized trial. Int J Radiat Oncol Biol Phys 2000, 47:925-929.
45. Muller G., Kiricuta I.C., Stiess J., et al. [Radiation pneumonitis and pulmonary fibrosis after the CT-planned radiotherapy of bronchial carcinoma]. Strahlenther Onkol 1994, 170:400-407.
46. Monson J.M., Stark P., Reilly J.J., et al. Clinical radiation pneumonitis and radiographic changes after thoracic radiation therapy for lung carcinoma. Cancer 1998, 82:842-850.
47. Pickel H., Lahousen M., Petru E., et al. Consolidation radiotherapy after carboplatin-based chemotherapy in radically operated advanced ovarian cancer. Gynecol Oncol 1999, 72:215-219.
48. Sorbe B., Ovarian S.-N. Consolidation treatment of advanced (FIGO stage III) ovarian carcinoma in complete surgical remission after induction chemotherapy: A randomized, controlled, clinical trial comparing whole abdominal radiotherapy, chemotherapy, and no further treatment. Int J Gynecol Cancer 2003, 13:278-286. Cancer Study Group.
49. Umsawasdi T., Valdivieso M., Chen T.T., et al. Role of elective brain irradiation during combined chemoradiotherapy for limited disease non-small cell lung cancer. J Neurooncol 1984, 2:253-259.
50. Stuschke M., Eberhardt W., Pottgen C., et al. Prophylactic cranial irradiation in locally advanced non-small-cell lung cancer after multimodality treatment: Long-term follow-up and investigations of late neuropsychologic effects. J Clin Oncol 1999, 17:2700-2709.
51. Pottgen C., Eberhardt W., Grannass A., et al. Prophylactic cranial irradiation in operable stage IIIA nonsmall-cell lung cancer treated with neoadjuvant chemoradiotherapy: Results from a German multicenter randomized trial. J Clin Oncol 2007, 25:4987-4992.
52. Quaranta B.P., Light K.L., Das S., et al. Utility of non-axial beams for treatment of lower lobe lung cancers. Int J Radiat Oncol Biol Phys 2002, 54. 337-337.